Company news
Aptevo Therapeutics Inc. news in 2020
Aptevo Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.
Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442
December 1, 2020
Aptevo Therapeutics Reports Third Quarter Financial Results and Provides Business Update
November 9, 2020
Aptevo Therapeutics Announces Second Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
November 8, 2020
Aptevo Therapeutics Adopts Limited Duration Stockholder Rights Plan
November 7, 2020
Aptevo Therapeutics Announces First Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
November 2, 2020
Aptevo Therapeutics Reports Second Quarter 2020 Financial Results
August 13, 2020
Aptevo Therapeutics Secures $25 Million Non-Dilutive Financing from Midcap Financial Trust
August 5, 2020
Aptevo Therapeutics Collects $750,000 Working Capital Escrow From Medexus Related to IXINITY(R) Sale
June 28, 2020
Aptevo Therapeutics Reports First Quarter 2020 Financial Results
May 12, 2020
Aptevo Therapeutics Regains Compliance With Nasdaq Listing Requirements
April 13, 2020
Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update
March 24, 2020
Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial
March 15, 2020
Aptevo Therapeutics Doses First Patient in IXINITY Clinical Trial for Potential Pediatric Label Expansion
January 29, 2020